fda import alert semaglutide tirzepatide green list creates "green list" to block unsafe GLP-1 imports | FDA posted on the topic fda import alert green list

Six markers split reputable from risky pharmacies

M., Jedrychowski, M

CYP2C19 poor metabolizers In CYP2C19 poor metabolizers, citalopram steady state Cmax and AUC was increased by 68% and 107%, respectively

This combination is usually hard to find in the medical community

Metformin may be preferred when Youre early in T2D treatment You want a well-established option Cost is a major factor You tolerate it (or can tolerate XR) Jardiance may be preferred or added when Your clinician is targeting more than A1C alone (based on your health history) Metformin alone isnt reaching your A1C goal You and your clinician are balancing blood sugar control with other clinical priorities Bottom line: The best medicine is the one that fits your body, your risks, your goals, and that you can keep taking

This article breaks down the costs associated with GLP-1 drugs and what to consider